| Arabidopsis thaliana |
AT2G36000 |
Plastid |
accD
|
1568 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 33.18% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 41.06% | Medium | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 26.36% | Low | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
accD
|
794 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 63.33% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 50.61% | Medium | Decreased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 39.24% | Low | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
atpF
|
92 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 71.21% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 63.79% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 75.15% | High | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
clpP
|
559 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 16.67% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 35.91% | Low | Increased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 27.27% | Low | Increased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
matK
|
640 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 78.33% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 68.64% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 70.91% | High | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
1255 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 20.45% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 21.67% | Low | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 40.91% | Medium | Increased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
1481 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 5.30% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 3.64% | Poor | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 3.48% | Poor | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
149 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 43.64% | Medium | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 21.67% | Low | Decreased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 20.00% | Low | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
467 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 57.58% | Medium | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 15.91% | Poor | Decreased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 28.18% | Low | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
586 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 10.91% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 11.82% | Poor | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 25.61% | Low | Increased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
746 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 38.94% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 22.88% | Low | Decreased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 36.21% | Low | Restored | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
830 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 21.36% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 10.76% | Poor | Decreased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 9.55% | Poor | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
836 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 12.42% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 4.55% | Poor | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 6.06% | Poor | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhB
|
872 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 21.97% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 9.24% | Poor | Decreased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 7.73% | Poor | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhD
|
2 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 6.06% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 5.61% | Poor | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 7.88% | Poor | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhD
|
383 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 88.94% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 70.30% | High | Decreased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 58.03% | Medium | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhD
|
674 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 86.67% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 86.97% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 74.70% | High | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhD
|
878 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 76.36% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 67.88% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 70.91% | High | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhD
|
887 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 79.09% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 83.18% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 74.24% | High | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhF
|
290 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 52.58% | Medium | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 63.94% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 21.52% | Low | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
ndhG
|
50 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 45.30% | Medium | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 40.91% | Medium | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 34.55% | Low | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
petL
|
5 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 19.39% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 23.18% | Low | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 9.39% | Poor | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
psbE
|
214 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 96.21% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 95.00% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 95.15% | High | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
psbF
|
77 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 90.45% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 93.33% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 90.00% | High | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
psbZ
|
50 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 21.21% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 34.24% | Low | Increased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 24.85% | Low | Restored | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rpl23
|
89 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 8.79% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 6.21% | Poor | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 5.61% | Poor | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rpoA
|
200 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 34.55% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 38.79% | Low | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 52.12% | Medium | Increased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rpoB
|
2432 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 71.67% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 70.15% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 63.64% | High | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rpoB
|
338 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 62.12% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 72.58% | High | Increased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 40.30% | Medium | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rpoB
|
551 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 69.39% | High | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 75.61% | High | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 49.85% | Medium | Decreased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rpoC1
|
488 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 49.39% | Medium | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 71.36% | High | Increased | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 71.21% | High | Increased | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rps12
|
58 |
Intron |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 25.91% | Low | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 31.06% | Low | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 28.79% | Low | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rps14
|
149 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 5.30% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 2.58% | Poor | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 3.94% | Poor | Similar | 41995017 |
|
| Arabidopsis thaliana |
AT2G36000 |
Plastid |
rps14
|
80 |
CDS |
NA |
NA |
NA |
NA |
C-to-U |
NA=>NA |
NA=>NA |
NA |
|
Experiment Details
| Genotype (Ecotype) |
Allele |
Treatment |
Treatment Detail |
Mutant Type |
Phenotype |
Tissue |
Development Stage |
Detection Method |
Editing Frequency |
Editing Extent |
Mutant Effect |
PMID |
| Columbia (Col-0) | WT | Norflurazon treatment | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | No mutant | Normal | Leaf | NA | Bulk sequencing of PCR products | 8.33% | Poor | None | 41995017 | | Columbia (Col-0) | sl1 | Norflurazon treatment; A T-DNA insertion | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM | Heterozygous | Pale cotyledons and seedling lethality | Leaf | NA | Bulk sequencing of PCR products | 7.58% | Poor | Similar | 41995017 | | Columbia (Col-0) | Com | Norflurazon treatment; Complementation | Norflurazon (Aladdin) was added to the medium at a final concentration of 5 μM; The full-length coding sequence of the SL1 gene was amplified from Arabidopsis cDNA, and the fragment was ligated into t | Heterozygous | Normal | Leaf | NA | Bulk sequencing of PCR products | 5.30% | Poor | Similar | 41995017 |
|